Pasadhika et al. have shown that LCA1 patients retain all retinal layers, and might benefit from gene therapy even more than other forms of LCA, where photoreceptor cell survival is compromised earlier [14, 15]. The gene discussed is GUCY2D; the disease is Leber congenital amaurosis.